Torgny H. Svensson

Corporate Officer/Principal at Karolinska Institutet

Distribution Services

Consumer Services

Profile

Torgny H.
Svensson is the founder of Independent Pharmaceutica AB, which was founded in 1997.
He held the title of Vice President from 2009 to 2011.
Currently, he is a Professor at Karolinska Institutet.

Torgny H. Svensson active positions

Companies	Position	Start
Karolinska Institutet	Corporate Officer/Principal	-

All active positions of Torgny H. Svensson

Former positions of Torgny H. Svensson

Companies	Position	End
Independent Pharmaceutica AB Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved.	Founder	2011-10-19

See the detail of Torgny H. Svensson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Torgny H. Svensson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Independent Pharmaceutica AB Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved.	Distribution Services